PHARMAVENE INC has a total of 25 patent applications. Its first patent ever was published in 1991. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and United States. Its main competitors in its focus markets pharmaceuticals, machines and biotechnology are PHARMA PASS LLC, HAUSER KUHRTS INC and L A M PHARMACEUTICALS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | Canada | 5 | |
#3 | United States | 5 | |
#4 | Australia | 3 | |
#5 | Mexico | 2 | |
#6 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Unspecified technologies | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Rudnic Edward M | 21 |
#2 | Mccarty John A | 12 |
#3 | Belenduik George W | 12 |
#4 | Belendiuk George W | 10 |
#5 | Burnside Beth A | 8 |
#6 | Mcguinness Charlotte M | 7 |
#7 | Mattes Carol E | 6 |
#8 | Lynch Thomas J | 3 |
#9 | Mcguinnes Charlotte M | 1 |
Publication | Filing date | Title |
---|---|---|
WO9525504A1 | Emulsified drug delivery systems | |
US5447729A | Multilamellar drug delivery systems | |
US5484608A | Sustained-release drug delivery system | |
US5430021A | Hydrophobic drug delivery systems | |
WO9221333A2 | Treatment of drug withdrawal symptoms and drug craving with type b monoamine oxidase inhibitors | |
US5326570A | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine | |
US5272080A | Production of butyrylcholinesterase |